Explore the Effect of Diet Intervention on Lipid Metabolism and Body Mass Index Among the Patients With Metabolic Syndrome
NCT04475822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 169
Last updated 2022-07-11
Summary
The prevalence of metabolic syndrome (MetS) is increasing all over the world, which is largely related to the increasing obesity population and the current inactive lifestyle of human beings. It is a common problem facing public health and clinical practice.Metabolic syndrome is an accumulation of biologically metabolic risk factors related to cardiovascular disease and diabetes, including glucose metabolism disorders, hypertension, dyslipidemia, and obesity (especially central obesity).Researchers believe that the common pathological basis of these manifestations is insulin resistance, which is generally considered to be a reduction in the biological effects of insulin compared with the normal biological effects of expected biological phenomena.Nowadays, there are more and more studies on insulin resistance in the world. We have known that age, poor living and eating habits, high blood fat, high blood sugar and stress all lead to insulin resistance.
The researchers hope to reduce weight, reduce body fat rate, improve body fat distribution and insulin resistance, reverse abnormal metabolic indicators, and ultimately reduce the incidence of chronic diseases in patients with metabolic syndrome through the intervention of lifestyle and diet habits in the early stage of the disease.
Conditions
- Metabolic Syndrome
Interventions
- BEHAVIORAL
-
Intermittent fasting
Intermittent fasting group:During the three-month intervention period, participants were allowed to eat for eight consecutive hours and fast for 16 hours a day.The eating time can be freely chosen in the following two periods: 8:00 -- 16:00;12:00 -- 20:00.No specific restriction shall be made on the type and quantity of food.
- BEHAVIORAL
-
Low carb diet
Low carb diet:The daily carbohydrate intake of participants in this group was limited to 130g/ D, and the recommended diet was formulated according to the standard and combined with the local eating habits in Xi 'an, and dietary habit education was conducted. Participants could eat according to the recommended diet.
- BEHAVIORAL
-
Low carbon diet and intermittent fasting group
Low carbon diet and intermittent fasting group:Participants fasted for 16 hours a day and ate for eight consecutive hours on the same diet as the low-carb group.
Sponsors & Collaborators
-
The Hospital for Sick Children
collaborator OTHER -
Leiden University
collaborator OTHER -
First Affiliated Hospital Xi'an Jiaotong University
lead OTHER
Principal Investigators
-
Bingyin Shi · First Affilicated Hospital of Xian Jiaotong University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-12
- Primary Completion
- 2021-01-31
- Completion
- 2022-06-30
Countries
- China
Study Locations
More Related Trials
-
Exploring the Mechanism of Dietary Pattern Improving MAFLD
NCT05960396 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Metabolically Normal and Metabolically Abnormal Obesity
NCT01184170 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Diet- and Exercise- Related Weight Control Intervention Program on Obesity in Adult Aged 40 and Over
NCT01040546 ·Status: COMPLETED ·Phase: NA
-
The Effects of Low Glycemic Index (GI) Diet on Cardiometabolic Outcomes Among Obese Chinese Adults
NCT04152213 ·Status: COMPLETED ·Phase: NA
-
Metabolic Syndrome and Degenerative Meniscus Lesions Related Knee Function
NCT04921202 ·Status: COMPLETED
-
Natural Course of Initially Metabolic Healthy Obese Individuals (Healthy Obesity)?
NCT06799897 ·Status: RECRUITING
-
Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults
NCT03972631 ·Status: UNKNOWN ·Phase: NA
-
Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease
NCT04463667 ·Status: UNKNOWN ·Phase: NA
-
Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver
NCT01477307 ·Status: COMPLETED
-
Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)
NCT07083336 ·Status: RECRUITING ·Phase: NA
-
Impact of Health Lifestyle on Body Weight
NCT05608226 ·Status: UNKNOWN
-
How Metabolism Affects Weight Loss and Gain
NCT06860776 ·Status: RECRUITING
-
Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health
NCT02706288 ·Status: COMPLETED ·Phase: NA
-
Body Weight and Vascular Function
NCT01675401 ·Status: COMPLETED ·Phase: NA
-
Effects of Fat and Carbohydrates in Obese Men
NCT01750021 ·Status: COMPLETED ·Phase: NA
-
Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines
NCT06257732 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
NCT03141008 ·Status: COMPLETED
-
Effects of Three Dietary Strategies on Body Composition and Metabolic Health in Adults With Overweight or Obesity
NCT07314177 ·Status: COMPLETED ·Phase: NA
-
Effect of Dietary Interventions on Intestinal Flora and Metabolism
NCT04140851 ·Status: UNKNOWN ·Phase: NA
-
Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
NCT06135584 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fatty Liver Disease Collaborative Research in China
NCT02391168 ·Status: UNKNOWN
-
Dynamics of Gut Microbiome in Overweight or Obese Participants on a Modified Atkins Diet
NCT07212556 ·Status: WITHDRAWN
-
Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity
NCT04442620 ·Status: UNKNOWN ·Phase: NA
-
The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease
NCT03164005 ·Status: COMPLETED
-
Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
NCT05738707 ·Status: NOT_YET_RECRUITING